Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hanna Bayer

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Pflege Zeitschrift|March 22, 2013
[At first they found no one in their country who would listen to them]Heike Rüger, Hanna Bayer, Barbel Ladner
Neurochemistry International|August 23, 2017
Contrasting effects of selective MAGL and FAAH inhibition on dopamine depletion and GDNF expression in a chronic MPTP mouse model of Parkinson's diseaseNoemi Pasquarelli, Christoph Porazik, Hanna Bayer, et al.
Frontiers in Molecular Neuroscience|June 13, 2017
Comparison of Sirtuin 3 Levels in ALS and Huntington's Disease-Differential Effects in Human Tissue Samples vs. Transgenic Mouse ModelsEva Buck, Hanna Bayer, Katrin S Lindenberg, et al.
Neuropharmacology|April 5, 2017
Evaluation of monoacylglycerol lipase as a therapeutic target in a transgenic mouse model of ALSNoemi Pasquarelli, Michael Engelskirchen, Johannes Hanselmann, et al.
Scientific Reports|August 19, 2017
Ribosomal transcription is regulated by PGC-1alpha and disturbed in Huntington's diseaseSarah Jesse, Hanna Bayer, Marius C Alupei, et al.
Human Molecular Genetics|May 15, 2013
PGC-1α is a male-specific disease modifier of human and experimental amyotrophic lateral sclerosisJudith Eschbach, Birgit Schwalenstöcker, Selma M Soyal, et al.
Neurobiology of Disease|November 8, 2016
ALS-causing mutations differentially affect PGC-1α expression and function in the brain vs. peripheral tissuesHanna Bayer, Kerstin Lang, Eva Buck, et al.
Acta Neuropathologica|November 19, 2015
Age-dependent defects of alpha-synuclein oligomer uptake in microglia and monocytesCorinna Bliederhaeuser, Veselin Grozdanov, Anna Speidel, et al.
Annals of Neurology|November 4, 2014
Mutual exacerbation of peroxisome proliferator-activated receptor γ coactivator 1α deregulation and α-synuclein oligomerizationJudith Eschbach, Björn von Einem, Kathrin Müller, et al.
Acta Neuropathologica|January 9, 2016
Serotonin 2B receptor slows disease progression and prevents degeneration of spinal cord mononuclear phagocytes in amyotrophic lateral sclerosisHajer El Oussini, Hanna Bayer, Jelena Scekic-Zahirovic, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Pflege Zeitschrift|March 22, 2013
[At first they found no one in their country who would listen to them]Heike Rüger, Hanna Bayer, Barbel Ladner
Neurochemistry International|August 23, 2017
Contrasting effects of selective MAGL and FAAH inhibition on dopamine depletion and GDNF expression in a chronic MPTP mouse model of Parkinson's diseaseNoemi Pasquarelli, Christoph Porazik, Hanna Bayer, et al.
Frontiers in Molecular Neuroscience|June 13, 2017
Comparison of Sirtuin 3 Levels in ALS and Huntington's Disease-Differential Effects in Human Tissue Samples vs. Transgenic Mouse ModelsEva Buck, Hanna Bayer, Katrin S Lindenberg, et al.
Neuropharmacology|April 5, 2017
Evaluation of monoacylglycerol lipase as a therapeutic target in a transgenic mouse model of ALSNoemi Pasquarelli, Michael Engelskirchen, Johannes Hanselmann, et al.
Scientific Reports|August 19, 2017
Ribosomal transcription is regulated by PGC-1alpha and disturbed in Huntington's diseaseSarah Jesse, Hanna Bayer, Marius C Alupei, et al.
Human Molecular Genetics|May 15, 2013
PGC-1α is a male-specific disease modifier of human and experimental amyotrophic lateral sclerosisJudith Eschbach, Birgit Schwalenstöcker, Selma M Soyal, et al.
Neurobiology of Disease|November 8, 2016
ALS-causing mutations differentially affect PGC-1α expression and function in the brain vs. peripheral tissuesHanna Bayer, Kerstin Lang, Eva Buck, et al.
Acta Neuropathologica|November 19, 2015
Age-dependent defects of alpha-synuclein oligomer uptake in microglia and monocytesCorinna Bliederhaeuser, Veselin Grozdanov, Anna Speidel, et al.
Annals of Neurology|November 4, 2014
Mutual exacerbation of peroxisome proliferator-activated receptor γ coactivator 1α deregulation and α-synuclein oligomerizationJudith Eschbach, Björn von Einem, Kathrin Müller, et al.
Acta Neuropathologica|January 9, 2016
Serotonin 2B receptor slows disease progression and prevents degeneration of spinal cord mononuclear phagocytes in amyotrophic lateral sclerosisHajer El Oussini, Hanna Bayer, Jelena Scekic-Zahirovic, et al.
Pageof 1